Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals (NQ: AGIO )

44.03 USD +0.44 (+1.01%)
Official Closing Price Updated: 4:54 PM EST, Nov 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 513,134
Open 43.61
Bid (Size) 38.00 (1)
Ask (Size) 45.00 (2)
Prev. Close 43.59
Today's Range 43.46 - 44.98
52wk Range 27.77 - 56.74
Shares Outstanding 57,605,621
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease
From GlobeNewswire News Releases
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
From GlobeNewswire News Releases

Performance

YTD
-7.34%
-7.34%
1 Month
+15.75%
+15.75%
3 Month
+15.38%
+15.38%
6 Month
-16.05%
-16.05%
1 Year
+16.30%
+16.30%

More News

Read More
Agios to Present Broad Set of Clinical and Translational Data for Oncology and Rare Genetic Disease Programs at the Virtual 2020 ASH Annual Meeting
From GlobeNewswire News Releases
Agios to Host a Webinar on its Pyruvate Kinase-R (PKR) Activation Clinical Programs and Commercial Outlook on Thursday, November 19, 2020
From GlobeNewswire News Releases
Agios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020
From GlobeNewswire News Releases
Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute Myeloid Leukemia
From GlobeNewswire News Releases
Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients
From GlobeNewswire News Releases
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
From GlobeNewswire News Releases
Noteworthy Friday Option Activity: CRTX, AGIO, DELL
Tags Stocks
From Market News Video
Unusual Options Activity Insight: Agios Pharmaceuticals
Tags AGIO General Markets
From Benzinga
Agios to Present at the Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.